# FDA Inspection 1266243 - Biomat USA, Inc. - March 24, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/ed3733c0-ee4b-476f-949b-c083da676bbd
Source feed: FDA_Inspections

> FDA Inspection 1266243 for Biomat USA, Inc. on March 24, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1266243
- Company Name: Biomat USA, Inc.
- Inspection Date: 2025-03-24
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1266243 - 2025-03-24](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/305ba016-ea69-43f8-b067-f74e18c94e5f)
- [FDA Inspection 1077502 - 2019-01-23](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/d667a90d-d77d-45c5-b34e-94bee7fc213e)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/ea42fb19-ed3b-489a-8f9a-c2739997b431

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d